Nyrada Inc

Research Nyrada Inc (NYR) on Bullrun: market cap AUD 102.88M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNYR
• ExchangeAU
• CountryAustralia
• SectorHealthcare
• IndustryBiotechnology
• CurrencyAUD
• Market capAUD 102.88M
• Financial periodFY2025
• Net income-AUD 4.85M
• Free cash flow-AUD 5.05M

Valuation Snapshot

latest market cap is AUD 102.88M.

About Nyrada Inc

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases. Its lead candidate is Xolatryp, a small molecule drug which has completed phase 1 clinical trial for neuroprotection and cardioprotection indications and in patients with traumatic brain injury and ischaemic stroke. Nyrada Inc. was incorporated in 2017 and is based in Sydney, Australia.

Frequently asked questions

What is Nyrada Inc's market cap?

Nyrada Inc's market capitalization is AUD 102.88M.

What does Nyrada Inc do?

Nyrada Inc., a pre-clinical stage drug development company, engages in the development of small molecule drugs for cardiovascular and neurological diseases.